Greg S. Warnick
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Global Cancer Incidence and Screening 2
- Colorectal Cancer Treatments and Studies 1
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- David García (4 shared papers)Qian Wu (4 shared papers)Edward N. Libby (4 shared papers)Ang Li (4 shared papers)Gary H. Lyman (4 shared papers)Neil A. Zakai (2 shared papers)Suhong Luo (1 shared paper)Brian F. Gage (1 shared paper)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (1 paper)Journal of the National Comprehensive Cancer Network (1 paper)American Journal of Epidemiology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United States
In The Last Decade
Greg S. Warnick
7 papers receiving 184 citations
Peers
Comparison fields: 5 of 54
- Internal Medicine 78
- Hematology 79
- Genetics 38
- Cardiology and Cardiovascular Medicine 45
- Oncology 39
Countries citing papers authored by Greg S. Warnick
This map shows the geographic impact of Greg S. Warnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg S. Warnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg S. Warnick more than expected).
Fields of papers citing papers by Greg S. Warnick
This network shows the impact of papers produced by Greg S. Warnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg S. Warnick. The network helps show where Greg S. Warnick may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg S. Warnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2015 | 40 | |
| 3 | 2020 | 22 | |
| 4 | 2019 | 18 | |
| 5 | 2018 | 5 | |
| 6 | 2017 | 1 | |
| 7 | 2018 | 1 |
About Greg S. Warnick
Greg S. Warnick is a scholar working on Oncology, Hematology, Internal Medicine, Economics and Econometrics and Surgery, having authored 7 papers that have together received 185 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Global Cancer Incidence and Screening (2 papers), Economic and Financial Impacts of Cancer (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Breast Cancer Treatment Studies (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Internal Medicine (78 citations), Hematology (79 citations), Genetics (38 citations), Cardiology and Cardiovascular Medicine (45 citations) and Oncology (39 citations). Greg S. Warnick has collaborated with scholars based in United States. Frequent co-authors include David García, Qian Wu, Edward N. Libby, Ang Li, Gary H. Lyman, Neil A. Zakai, Suhong Luo, Brian F. Gage, Kristen M. Sanfilippo and Betsy Rolland. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, American Journal of Epidemiology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.